Literature DB >> 16930562

Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage?

Jonathan D Turner1, Andrea B Schote, Joana A Macedo, Laetitia P L Pelascini, Claude P Muller.   

Abstract

The CpG island upstream of the GR is highly structured and conserved at least in all the animal species that have been investigated. Sequence alignment of these CpG islands shows inter-species homology ranging from 64 to 99%. This 3.1kb CpG rich region upstream of the GR exon 2 encodes 5' untranslated mRNA regions. These CpG rich regions are organised into multiple first exons and, as we and others have postulated, each with its own promoter region. Alternative mRNA transcript variants are obtained by the splicing of these alternative first exons to a common acceptor site in the second exon of the GR. Exon 2 contains an in-frame stop codon immediately upstream of the ATG start codon to ensure that this 5' heterogeneity remains untranslated, and that the sequence and structure of the GR is unaffected. Tissue specific differential usage of exon 1s has been observed in a range of human tissues, and to a lesser extent in the rat and mouse. The GR expression level is tightly controlled within each tissue or cell type at baseline and upon stimulation. We suggest that no single promoter region may be capable of containing all the necessary promoter elements and yet preserve the necessary proximity to the transcription initiation site to produce such a plethora of responses. Thus we further suggest that alternative first exons each under the control of specific transcription factors control both the tissue specific GR expression and are involved in the tissue specific GR transcriptional response to stimulation. Spreading the necessary promoter elements over multiple promoter regions, each with an associated alternative transcription initiation site would appear to vastly increase the capacity for transcriptional control of GR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930562     DOI: 10.1016/j.bcp.2006.07.005

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  34 in total

Review 1.  Minireview: latest perspectives on antiinflammatory actions of glucocorticoids.

Authors:  Karolien De Bosscher; Guy Haegeman
Journal:  Mol Endocrinol       Date:  2008-12-18

2.  Corticosteroid use in neuro-oncology: an update.

Authors:  Patrick Roth; Caroline Happold; Michael Weller
Journal:  Neurooncol Pract       Date:  2014-10-09

3.  Transcriptional control of the human glucocorticoid receptor: identification and analysis of alternative promoter regions.

Authors:  Lei Cao-Lei; Salomon Carlos Leija; Robert Kumsta; Stefan Wüst; Jobst Meyer; Jonathan D Turner; Claude P Muller
Journal:  Hum Genet       Date:  2011-01-15       Impact factor: 4.132

4.  Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome.

Authors:  Grzegorz Zalewski; Anna Wasilewska; Walentyna Zoch-Zwierz; Lech Chyczewski
Journal:  Pediatr Nephrol       Date:  2008-03-15       Impact factor: 3.714

Review 5.  Role of the hypothalamic-pituitary-adrenal axis in developmental programming of health and disease.

Authors:  Fuxia Xiong; Lubo Zhang
Journal:  Front Neuroendocrinol       Date:  2012-11-27       Impact factor: 8.606

6.  Identification of transcription start sites and preferential expression of select CB2 transcripts in mouse and human B lymphocytes.

Authors:  Tracy A Sherwood; Liang Nong; Marisela Agudelo; Cathy Newton; Ray Widen; Thomas W Klein
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-16       Impact factor: 4.147

7.  Fetal hypoxia increases vulnerability of hypoxic-ischemic brain injury in neonatal rats: role of glucocorticoid receptors.

Authors:  Pablo J Gonzalez-Rodriguez; Fuxia Xiong; Yong Li; Jianjun Zhou; Lubo Zhang
Journal:  Neurobiol Dis       Date:  2014-02-07       Impact factor: 5.996

8.  A conserved molecular mechanism is responsible for the auto-up-regulation of glucocorticoid receptor gene promoters.

Authors:  Chuan-dong Geng; Jason R Schwartz; Wayne V Vedeckis
Journal:  Mol Endocrinol       Date:  2008-10-22

9.  Activation of alternative Jdp2 promoters and functional protein isoforms in T-cell lymphomas by retroviral insertion mutagenesis.

Authors:  Mads Heilskov Rasmussen; Bruce Wang; Matthias Wabl; Anders Lade Nielsen; Finn Skou Pedersen
Journal:  Nucleic Acids Res       Date:  2009-06-05       Impact factor: 16.971

10.  Predicting functional alternative splicing by measuring RNA selection pressure from multigenome alignments.

Authors:  Hongchao Lu; Lan Lin; Seiko Sato; Yi Xing; Christopher J Lee
Journal:  PLoS Comput Biol       Date:  2009-12-18       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.